[DNLI] QoQ Quarter Result on 31-Dec-2018 [#Q4]

Stock
[DNLI] Denali Therapeutics Inc.
Announcement Date
12-Mar-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- 319.20%
YoY- 438.76%
Quarter Report
DNLI's Result
DNLI's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Revenue 13,604 4,197 4,205 125,676 1,195 1,648 641 665.12%
PBT -46,373 -58,650 -38,992 77,533 -35,371 -54,724 -23,678 56.47%
Tax -113 -313 0 -2,379 0 0 0 -
NP -46,260 -58,337 -38,992 77,533 -35,371 -54,724 -23,678 56.21%
Tax Rate - - - 3.07% - - - -
Total Cost 59,864 62,534 43,197 48,143 36,566 56,372 24,319 82.21%
Ratio Analysis
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
NP Margin -340.05 -1,389.97 -927.28 61.69 -2,959.92 -3,320.63 -3,693.92 -79.58%
Per Share
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
EPS -0.48 -0.61 -0.41 0.82 -0.38 -0.59 -0.26 50.43%
EPS Diluted -0.48 -0.61 -0.41 0.79 -0.38 -0.59 -0.26 50.43%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.